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The plague-causing bacterium Yersinia pestis utilizes a type III secretion
system to deliver effector proteins into mammalian cells where they
interfere with signal transduction pathways that mediate phagocytosis and
the inflammatory response. Effector proteins are injected through a hollow
needle structure composed of the protein YscF. YscG and YscE act as
“chaperones” to prevent premature polymerization of YscF in the cytosol of
the bacterium prior to assembly of the needle. Here, we report the crystal
structure of the YscEFG protein complex at 1.8 Å resolution. Overall, the
structure is similar to that of the analogous PscEFG complex from the
Pseudomonas aeruginosa type III secretion system, but there are noteworthy
differences. The structure confirms that, like PscG, YscG is a member of the
tetratricopeptide repeat family of proteins. YscG binds tightly to the C-
terminal half of YscF, implying that it is this region of YscF that controls its
polymerization into the needle structure. YscE interacts with the N-terminal
tetratricopeptide repeat motif of YscG but makes very little direct contact
with YscF. Its function may be to stabilize the structure of YscG and/or to
participate in recruiting the complex to the secretion apparatus. No electron
density could be observed for the 49 N-terminal residues of YscF. This and
additional evidence suggest that the N-terminus of YscF is disordered in the
complex with YscE and YscG. As expected, conserved residues in the C-
terminal half of YscF mediate important intra- and intermolecular
interactions in the complex. Moreover, the phenotypes of some previously
characterized mutations in the C-terminal half of YscF can be rationalized in
terms of the structure of the heterotrimeric YscEFG complex.
Published by Elsevier Ltd.
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Introduction
Yersinia pestis, the causative agent of plague, is
arguably the deadliest pathogen in history and a
likely instrument of bioterrorism.
1,2 Like many other
Gram-negative bacterial pathogens of plants and
animals, Y. pestis relies on a contact-dependent type
III secretion system (T3SS) to deliver a small number
of proteins, termed effectors, through a hollow
needle extending across the inner and outer mem-
branes of the bacterium and into the cytosol of
eukaryotic cells.
3,4 These effector Yops (Yersinia outer
proteins) interfere with signal transduction path-
ways that regulate the actin cytoskeleton, phagocy-
tosis, apoptosis, and the inflammatory response,
thereby favoring survival of the bacteria.5 More than
20 proteins are involved in the assembly of the
syringe-like type III secretion “injectisome,” a so-
called nanomachine.
6 The structure of the injecti-
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terial flagellum, confirming previous phylogenetic
analyses that revealed substantial sequence simila-
rities between several of their core components.
7
The assembly and operation of the injectisome are
assisted by a number of small bacterial proteins
termed T3SS chaperones. Several different types of
secretion chaperones have been recognized to date.
8
Class I chaperones, which are small acidic polypep-
tides that exhibit little sequence similarity but adopt
similar dimeric folds, generally interact with one
unique effector (or, less frequently, with two or three
effectors) and stimulate its secretion via the type III
pathway. Class II chaperones, which interact with
the translocator proteins of the T3SS that breach the
plasma membrane of mammalian cells (e.g., Yersinia
YopB and YopD), are somewhat larger and com-
posed in part of tetratricopeptide repeats (TPRs).
Flagellar chaperones, exemplified by FliS, have an
entirely different structure
9 and have therefore been
designated Class III. Because the CesA chaperone
that interacts with the EspA filament protein of the
T3SS in enteropathogenic Escherichia coli is structu-
rally distinct from the other classes,
10 it has been
designated Class IV. Finally, the unique structure of
Yersinia YscE,
11 the cochaperone (along with YscG)
for the needle protein YscF, prompted it to be
categorized as yet another type of secretion chaper-
one (Class V).
The structural diversity of secretion chaperones
may reflect their varying roles in type III secretion
and flagellar assembly. It is believed that the
principal function of Class I chaperones and CesA
is to mediate targeting of their cognate binding part-
ners to the type III secretion apparatus.
12 However,
recent evidence suggests that Class I chaperones
may also serve to mask aggregation-prone mem-
brane localization domains in their cognate ef-
fectors.
13 In addition to stimulating the secretion of
their binding partners, at least some Class II
chaperones also appear to play a regulatory role in
type III secretion.14,15 The main function of the Class
III chaperone FliS and the heterodimeric chaperone
YscE (Class V)/YscG, on the other hand, evidently is
to prevent premature polymerization of their cog-
nate binding partners (FliC and YscF, respectively)
prior to secretion.
9,16
The needles of the T3SSs in Yersinia, Salmonella,
Shigella, E. coli, Burkholderia, and Pseudomonas are
each composed primarily of a single protein (YscF,
PrgI, MxiH, EscF, BsaL, and PscF, respectively) that
polymerizes to form a hollow conduit
17–22 with an
inner diameter of 25 Å and a length of approxi-
mately 40–60 nm.
3 Efforts to elucidate the three-
dimensional structures of T3SS needle proteins
have been hampered by their tendency to poly-
merize into oligomers of varying sizes in vitro.
However, it was possible to create and crystallize
monomeric forms of two needle proteins, MxiH
20
and BsaL,
21 by deleting several residues from their
C-terminus. The crystal structures of both MxiH
and BsaL monomers revealed similar  -helical
hairpin conformations.
Quinaud et al. demonstrated that in Pseudomonas
aeruginosa, PscE and PscG trap the needle protein
PscF in a ternary 1:1:1 complex, blocking the poly-
merization of PscF.
16 An interaction between YscE
and YscG, the orthologs of PscE and PscG in Y. pes-
tis, had previously been identified by yeast two-
hybrid technology, suggesting the existence of a
similar complex in this organism.
23 To investigate
the detailed molecular architecture of the complex
between the cochaperones YscE/YscG and the
Yersinia needle protein YscF, we crystallized the
heterotrimer and determined its structure at a
resolution of 1.8 Å.
Results and Discussion
Similarities and differences between the
structures of YscE/YscF/YscG and
PscE/PscF(55–85)/PscG
The crystal structure of the YscE/YscF/YscG
multiprotein complex (YscEFG) was solved by the
SAD (single-wavelength anomalous dispersion) me-
thod using incorporated selenomethionine (Table 1).
The crystallographic asymmetric unit contains one
heterotrimer, which is consistent with a 1:1:1 stoi-
chiometry (Fig. 1). The final YscEFG model consists
Table 1. Data collection and refinement statistics
Parameter YscEFG complex
a
Data collection
Space group P21212
Cell dimensions
a, b, c (Å) 74.5, 94.5, 31.3
Wavelength (Å) 0.97942
Resolution (Å)
b 50–1.8 (1.86–1.80)
Rmerge
b 10.1 (36.9)
I/ Ib 11.9 (4.3)
Completeness (%)
b 98.6 (95.1)
Redundancy
b 6.5 (4.6)
Refinement statistics
Resolution (Å) 50–1.8
Unique reflections 20,372
Rwork/Rfree (%) 19.03/22.13
No. of atoms
Protein 1632
Water 227
B-factors (Å
2)
Protein
c 27.1/24.4/26.5
Water 40.5
RMSDs
Bond lengths (Å) 0.01
Bond angles (°) 1.4
Ramachandran plot statistics
Residues in most favored regions 177
Residues in additional allowed regions 7
Residues in generously allowed regions 0
Residues in disallowed regions 0
a Se-Met protein was used in a SAD experiment for structure
determination.
b Values in parentheses refer to the highest-resolution shell.
c Average B-factors for YscE, YscF, and YscG, respectively.
820 Structure of the YscEFG Complexof 204 amino acids, including residues 10–63 of
YscE, residues 50–87 of YscF, and residues 3–114 of
YscG.
During the preparation of this article, the struc-
ture of the analogous PscEFG complex from the
P. aeruginosa T3SS was reported.
24 The degree of
sequence identity between YscE, YscF, YscG, and
their respective counterparts in P. aeruginosa is 25%,
58%, and 53%. The overall protein sequence identity
between YscEFG and PscEFG is 48%, while the
RMSD between these two structures is about 6 Å. As
one might expect, the two structures are similar in
many respects (Fig. 1c), particularly the conforma-
tions of the YscG and PscG subunits, but there are
also some significant differences between them.
The YscE subunit of the complex is composed of
two  -helices,  1 (residues 10–33) and  2 (residues
37–60), which are connected by a three-residue loop,
as reported previously.
11 RMSD values between
C  atoms in the structure of YscE in the YscEFG
complex and that of the YscE dimer determined
previously
11 range from 1.64 to 3.57 Å, with the
predominate differences being in the relative
position of the two helices and the conformation
of the loop between them.
The conformations of YscE and PscE in their
respective complexes are also somewhat different.
The first nine residues of YscE are disordered in the
complex, whereas they form part of a contiguous
 -helix in the crystal structure of YscE by itself.
11 In
the structure of the PscEFG complex, the N-terminal
residues of PscE adopt yet another conformation,
this time in the form of an additional  -helix that
angles toward the inner face of PscG. The biological
significance of these different conformational states
is unclear and may be an artifact of crystal packing
since further truncation of the PscE polypeptide, to
remove the additional N-terminal  -helix, had no
impact on its ability to form a complex with PscF
and PscG, nor did it lead to a defect in type III
secretion.
24
Of the three pairs of homologous proteins in the
two complexes, YscG and PscG share the greatest
degree of structural similarity (RMSD=1.5 Å). The
Fig. 1. (a) Ribbon representation of the overall structure of the YscEFG complex. YscE, YscF, and YscG are colored
purple, lime, and gray, respectively. (b) Surface representation of the YscEFG complex. (c) Superposition of YscEFG
(magenta) and PscEFG (cyan) complexes.  -Helices are depicted as cylinders and labeled according to YscEFG.
821 Structure of the YscEFG Complexcrystal structure of the PscEFG complex revealed
that PscG is a member of the TPR family of
proteins,
24 a relationship that was not recognized
by sequence comparisons.
25 The TPR motif is an im-
perfect 34-amino-acid repeat that commonly func-
tions as a protein–protein interaction module and is
found in proteins from all three domains of life.
26
Although the amino acid sequences of TPRs are not
highly conserved, canonical positions at 8, 20, and 27
are usually occupied by small and sometimes hy-
drophobic residues. A sequence alignment between
YscG and a canonical TPR protein PP5
27 (RMSD=
3.9 Å) reveals that the TPR domains in YscG (and
PscG) are not strictly composed of 34 amino acids,
but all three canonical positions are occupied by
either alanine or leucine (Fig. 2).
Like PscG, YscG is composed of seven antiparallel
 -helices that form a right-handed superhelix with a
continuous helical groove. Its fold is similar to that of
the TPR protein LcrH,
28 the Class II secretion
chaperone for the translocators YopB, YopD, and
LcrV, with an RMSD of 3.5 Å (Fig. 2). The solvent-
exposed faces of helices  3– 7 of YscG are composed
primarily of charged residues, whereas residues
facing the interior of the protein are mainly nonpolar,
generating a hydrophobic groove for YscF binding
(discussed below). The two N-terminal helices of
YscG,  1 and  2, are packed against YscE through
hydrophobic interactions. There is very little direct
interaction between YscF and YscE in the complex.
The total buried surface area between YscE/F, YscE/
G,andYscF/Gis276,1548,and2724Å
2,respectively.
YscG acts as a scaffold to organize the assembly of
YscE and YscF into the heterotrimeric complex.
Hydrophobic residues on the concave surface of
YscG (Val7, Ala10, Leu14, Ala40, Leu43, Leu70,
Pro72, Trp73, Leu76, Tyr79, Met109, and Phe105)
interact with hydrophobic residues on YscF (Ile66,
Ile71, Met75, Met78, Met79, Ile82, Leu83, and Phe86)
(Fig. 3a). Similarly, hydrophobic interactions also
mediate contact between YscG (Leu5, Leu8, Leu9,
Ile12, Ile15, Ile28, and Trp31) and YscE (Ile17, Leu21,
Ala24, Val43, Ala50, Leu51, Ala54, Ile57, Ile58, and
Leu61) (Fig. 3b and c). An alignment of the amino
acid sequence of YscG with those of related proteins
reveals a pattern of conservation among these
hydrophobic residues (Fig. 3d).
Crystal structures of Class I secretion chaperones
bound to their cognate effectors have revealed that
the chaperone-binding domains of the latter mole-
cules are mostly nonglobular. Rather, they wrap
around the surface of the chaperones in an extended
Fig. 2. Comparison of YscG
with PP5 [Protein Data Bank (PDB)
ID: 1A17], PscG (PDB ID: 2UWJ)
and LcrH (PDB ID: 2VGY). (a) Su-
perposition of YscG (magenta), PP5
(blue), PscG (green), and LcrH
(yellow) with canonical residues (8,
20, and 27) from each TPR domain
represented as spheres. (b) Sequence
alignment of three TPR domains in
YscG,PP5,PscG,andLcrH.Thethree
conserved positions are colored red
and shaded yellow.
822 Structure of the YscEFG Complexconformation with some  -helical and  -strand
secondary structure.
29–33 Only the C-terminal half
of YscF (residues 50–87) could be observed in the
electron density maps. Residues 50–87 of YscF adopt
an  -helical hairpin conformation in the complex
with its cochaperones YscE and YscG. In this
respect, the interaction between YscF and YscG is
vaguely reminiscent of that between flagellin (FliC)
and the Class III flagellar chaperone FliS,9 since both
chaperones (YscG and FliS) engage the carboxyl
termini of their cognate fiber-forming partners in a
coiled-coil interaction.
The two  -helices in YscF are connected by a five-
residue loop (Ile64–Asn68). In addition to the
numerous hydrophobic interactions between YscF
and YscG described above (Fig. 3a), hydrophilic
interactions also seem to play an important role in
maintaining the conformation of YscF within the
complex. For example, the loop in YscF is very well
ordered and stabilized by a hydrogen bond with
YscG (Fig. 4a). Additionally, the side chains of Tyr79
andArg80fromthethirdTPRmotif ofYscGandthat
of Gln112 from the C-terminal  -helix of YscG form
hydrogen bonds with the main-chain constituents of
theloopresiduesinYscF,whilethesidechainofYscF
residue Asn68 forms a hydrogen bond with Gly108
of YscG. The hairpin loop between the two  -helices
in YscF is further stabilized by intramolecular
hydrogen bonds between O  of Gln55 and N  of
Lys76, between N  of Gln55 and O  of Asn59, and
between N  of Lys76 and O  of Gln80, as depicted in
Fig. 4b. The intramolecular hydrogen bond between
the two  -helices of YscF has the potential to exist in
all of its orthologs because Gln55 is absolutely
conserved and Lys76 is always either a lysine or an
arginine residue (Fig. 4c).
The helical hairpin conformation of YscF in the
YscEFG complex is distinct from those of the needle
Fig. 3. Interactions between YscG/YscF and YscG/YscE. (a) Hydrophobic interactions between YscG (green) and
YscF (magenta). The main-chain C  atoms of residues from YscG and YscF are represented as red and cyan spheres,
respectively. The secondary structures are labeled. (b) Surface electrostatic representation of the neutrally charged area
where YscG interacts with YscE (cyan). (c) Hydrophobic interactions between YscE (salmon) and YscG (green). The main-
chain C  atomsof residues fromYscG and YscEare depicted as redand blue spheres, respectively.(d) Sequence alignment
of YscG with related open reading frames from various bacterial species with residues numbered and secondary structure
elements labeled according to Y. pestis YscG. Identical residues and highly similar residues are highlighted in red and
yellow, respectively.
823 Structure of the YscEFG ComplexFig. 4. YscF is captured in a partly helical, monomeric conformation. (a) 2Fo Fc electron density for the loop region in
YscF is contoured at 1.2  . YscF and YscG are shown in yellow and green, respectively. Hydrogen bonds are represented
as broken lines in red. (b) Hydrogen-bond network between  1 and  2 in YscF. Gln55, Asn59, Lys76, and Gln80 are
depicted in gray ball-and-stick format. 2Fo Fc electron density around these four residues is contoured at 1.0   in green.
Hydrogen bonds are represented as broken lines in red. (c) Sequence alignment of YscF with related open reading frames
from other bacteria, with residues numbered according to YscF. Identical residues and highly similar residues are
highlighted in red and yellow, respectively. (d) Superposition of MxiH chain A (purple), MxiH chain B (cyan), and PscF
(green) with the C-terminal  -helix of YscF (yellow). Because the C-terminus of BsaL does not have a stable conformation,
it is not aligned. (e) Superposition of MxiH chain A (purple), MxiH chain B (cyan), and BsaL (red) onto the N-terminal
 -helix of YscF (yellow). Because the corresponding residues of PscF were observed to be in an extended conformation,
they were not included in the alignment.
824 Structure of the YscEFG Complexproteins from Shigella flexneri (MxiH) and Burkhol-
deria pseudomallei (BsaL), which were crystallized in
isolation (Fig. 4d and e). The structure of MxiH (with
four residues truncated from its C-terminus) consists
oftwoextendedhelicesconnectedbyashortPro-Ser-
Asn-Pro turn.
20 The NMR structure of BsaL (with
five residues deleted from its C-terminus) adopts a
similar hairpin conformation with a much shorter
C-terminal helix than MxiH.
21 The structure of PscF
in the PscEFG complex differs from that of the three
other needle proteins in that it forms just a single
 -helix (residues 68–85) that is similar to the C-ter-
minal helix observed in YscF.
24 The region of PscF
(residues 55–67) that is analogous to the N-terminal
helix and hairpin turn observed in YscF adopts an
extended conformation instead, with the N-terminal
half of this region protruding away from the com-
pact complex. The intramolecular hydrogen-bond
“bridge”betweenhighlyconservedGln55andLys76
in YscF may play an important role in maintaining
the helical hairpin fold of YscF. We note that the
residue equivalent to Gln55 in PscF was removed
and replaced by a methionine during genetic
engineering of the truncated polypeptide for crystal-
lization purposes. The absence of the corresponding
intramolecularhydrogenbondinPscFmaybeoneof
the reasons why its N-terminus was observed to be
in an extended (i.e., nonhelical) conformation in the
PscEFG complex. In addition, the chelate geometry
of the Ni
2+ ion that is bound to the N-terminus of
PscF, which was introduced from the well solution
during crystallization of the complex, is also worth
considering. The Ni
2+ ion is chelated by N of Met54,
N andNofHis55fromPscF,andN ofHis80froma
symmetry-relatedPscGmoleculeinthecrystallattice
(Fig. 5). Hence,the presence of this Ni
2+ ion may also
have had an impact on the conformation of the
N-terminal region of the truncated PscF protein in
the complex. Finally, we note that although several
potentially favorable sites for thermolysin cleavage
(hydrophobic residue in the P1  position) exist
withintheregionofYscFandPscFthatwasobserved
to be in an extended conformation in the latter
molecule, no fragments with these endpoints were
detected after digestion of the YscEFG complex with
thermolysin (see below). Taken together, these
observations lead us to conclude that the  -helical
hairpinconformationofYscFintheYscEFGcomplex
may be a more accurate representation of the bio-
logically relevant structure than is the conforma-
tion of PscF that is observed in its respective
complex. It is also worth noting that whereas the
manner in which the YscEFG complexes pack to-
gether in the P21212 crystal lattice would allow
enough room to accommodate the disordered
N-terminal residues of YscF, the packing of PscEFG
complexes in the P6222 lattice would not. This may
explain why it was not possible to obtain crystals
of the full-length PscF protein in complex with
PscE and PscG.
Biochemical and biophysical characterization of
the YscEFG complex
Because they are not observed in the electron
density maps of the YscEFG complex, either the 49
Fig. 5. Two symmetry-related
PscEFG complexes are linked toge-
ther by Ni
2+ ions. The lower com-
plex is colored with green (PscE),
cyan (PscF), magenta (PscG), and
blue (Ni
2+ ions). The symmetry-
related complex (upper) is shown
in yellow. Metal-coordinating resi-
dues are represented in ball-and-
stick format.
825 Structure of the YscEFG ComplexN-terminal residues of YscF are disordered in the
structureoftheheterotrimerortheN-terminalhalfof
YscF is absent from the crystal due to proteolytic
degradation.Severalexperimentswereperformedin
an effort to distinguish between these possibilities.
First, proteins extracted from crystals of the
complex were analyzed by electrospray ionization
mass spectrometry. Although strong signals were
obtained for YscG and YscE, no mass corresponding
to YscF or a fragment of YscF could be detected,
presumably due to poor ionization (data not
shown). Crystals of the YscEFG complex were
grown over the course of 10 days prior to freezing
in liquid nitrogen for data collection, yet when the
complex was incubated under crystallization condi-
tions for 10 days and analyzed by SDS-PAGE, no
degradation of YscF or the other two polypeptides
was observed. Next, we subjected the complex to
limited proteolysis using thermolysin (Fig. 6a). YscE
and YscG proved to be remarkably resistant to
proteolysis whereas YscF was rapidly degraded to
yield astable homogeneousfragment. This fragment
was unambiguously identified as consisting of
residues 52–87 of YscF by electrospray mass spectro-
metry and N-terminal amino acid sequencing (data
not shown). It is unclear why this fragment of YscF
could be readily detected by mass spectrometry
whereas the full-length protein could not. A new
expression vector was subsequently constructed to
produce a truncated form of YscF corresponding to
the product of the thermolysin digest (residues 52–
78), which was termed sYscF, and the ternary
complex of sYscEFG was purified by a method
similar to the one that was used to purify the full-
length YscEFG complex. No crystals of the sYscEFG
complex could be obtained. However, copurification
of sYscF with YscE and YscG demonstrated that
residues 52–87 of YscF are sufficient to bind tightly
to YscEG (data not shown).
Next, we compared the far-UV circular dichroism
(CD) spectra of the YscEFG and sYscEFG complexes
(Fig. 6b). The two spectra were very similar, lending
additional support to the hypothesis that the N-
terminus of YscF is disordered in the YscEFG
complex. Finally, we compared the stability of the
two complexes by conducting thermal melting expe-
riments monitored by CD (Fig. 6c). Both complexes
exhibited virtually identicalmelting transition temp-
eratures: 66.7 °C for YscEFG and 67 °C for sYscEFG.
Taken together, these results strongly suggest that
the 49 N-terminal residues of YscF are present but
disordered in crystals of the YscEFG complex. More-
over, the manner in which the molecules pack in the
crystal lattice creates gaps that could accommodate
the disordered residues.
On the role of YscE in the YscEFG complex
YscEisrequiredforthesecretionofYopsinYersinia
enterocolitica34 and Y. pestis,23 yet virtually all of the
Fig. 6. Biochemical and biophysical characterization of the YscEFG complex. (a) Limited proteolysis of the YscEFG
complex by thermolysin. Lane 1, molecular weight standards; lane 2, undigested YscEFG complex; lanes 3–7, YscEFG
complex treated with 1:4, 1:16, 1:64, 1:256, and 1:1024 dilutions of the thermolysin stock solution, respectively. (b) CD
spectra of YscEFG and sYscEFG complexes indicate that they have very similar  -helical content. (c) Melting curves of
YscEFG and sYscEFG recorded at 222 nm.
826 Structure of the YscEFG Complexintermolecular contacts with YscF in the YscEFG
complex are mediated by the cochaperone YscG. It is
not immediately obvious, therefore, what the func-
tion of YscE is. One possibility is that it serves to
stabilize the fold of YscG, as PscE has been proposed
to do for PscG.
16 Consistent with this hypothesis, a
Y. pestis mutant that lacks YscE fails to accumulate
YscG.
23 AsecondpossibilityisthattheroleofYscEis
toensurethatYscFisrecognizedbythetranslocation
apparatus and assimilated into the growing needle
structure at the proper time. However, there are no
obvious patches of highly conserved residues on the
surface of YscE that might mediate its interaction
with components of the secretion apparatus.
The phenotypes of some mutations in YscF can
be rationalized in terms of its interactions with
YscG
Two studies have examined the impact of indivi-
dual amino acid substitutions in YscF on type III
secretion. In one study, a genetic screen was devised
to identify mutations that are capable of secreting
Yops but which are defective in translocating them
into eukaryotic cells.
35 Because secretion requires a
functional needle structure, which, in turn, depends
on the ability of YscF to form a complex with its
cochaperones YscE and YscG, none of these muta-
tions would be expected to disrupt the YscEFG
complex. Consistent with this notion, nearly all of
the mutations that exhibit a translocation-defective
phenotype and which are located in the portion of
YscF that is visible in the electron density map of the
complex occur at solvent-exposed positions (Ile67,
Thr70, and Lys85). Only the side chain of the latter
residue engages in any hydrogen-bonding interac-
tions. Two mutations, I58V and S74G, resulted in a
reduction in secreted YscF but were evidently still
able to form functional needle structures. Unlike the
other residues, the side chains at these two positions
are partially buried in the complex and may there-
fore be mildly destabilizing.
In a second study, Torruellas et al. examined the
effectofaminoacidsubstitutionsontheregulationof
type III secretion by YscF.
36 Targeting conserved and
acidic residues for replacement by alanine and/or
cysteine, they were able to distinguish three pheno-
types: (1) mutations with no discernable effect (i.e.,
those that exhibited normal, regulated secretion), (2)
mutations that resulted in constitutive or unregu-
lated secretion, and (3) mutations that abolished
secretion altogether. None of the type 2 muta-
tions (constitutive secretion) were located in the
C-terminal portion of YscF that is visible in the com-
plexwithYscEandYscG.Onceagain,themajorityof
type1mutations(wild-typephenotype)locatedwith-
in the C-terminal half of YscF occurred at solvent-
exposed positions (Asp53, Asn59, Ser69, Arg73, and
Ser74). (Paradoxically, as discussed above, replace-
ment of Ser74 with glycine reduced the secretion of
YscF in the other study.) Alanine or cysteine substitu-
tions at two positions (Asp77 and Ile82) abolished the
secretion of YscF. The highly conserved Ile82 residue
islocatedattheinterfacebetweenYscGandYscF(Fig.
3a), and the mutant may therefore destabilize the
interaction between them. Asp77, on the other hand,
is a solvent-accessible residue on the outer surface of
YscF in the heterotrimeric complex. Therefore, the
secretion defect exhibited by this mutant is not the
result of the failure to properly interact with its cha-
perones YscE/G in cytosol. Instead, most likely, mut-
ation in D77 will influence the architecture between
needle monomers.
Evolutionary conservation of YscE, YscF, and
YscG orthologs in T3SSs
The sequencing of microbial genomes has re-
vealed the presence of T3SSs in a wide variety of
animal and plant pathogens.
37 Most of these have
open reading frames that exhibit significant se-
quence homology with YscF and other known T3SS
needle proteins (Fig. 4c). However, only a handful of
T3SSs possess recognizable orthologs of YscE and
YscG (e.g., Fig. 3d). This suggests that those or-
ganisms with T3SSs, which clearly encode needle
proteins but lack analogs of YscE and YscG, such as
S. flexneri and Salmonella typhimurium, evidently
employ a different mechanism to control premature
polymerization of their needle proteins prior to
assembly of the secretion apparatus.
Conclusions
The structural description of the YscEFG complex
represents another incremental step forward in the
ongoing effort to unravel the molecular mechanism
of type III secretion. Yet, we are still a long way from
understanding how different classes of T3SS sub-
strates are recognized by the nascent secretion ap-
paratus at the proper time and in the proper order.
Clearly, the structures of additional multiprotein
complexes, especially complexes between mobile
and membrane-bound components of the T3SS, will
be required to achieve this goal. The structure of the
Yersinia needle protein YscF in complex with YscE
and YscG is not the same as those of the monomeric
needle protein variants crystallized in isolation,
20,21
and the conformation of the needle proteins in the
context of the polymerized needle structure is
unlikely to be identical with either of these. The
dynamic nature of the T3SS, a nanomachine com-
posed of many moving parts, presents a formidable
challenge for structural biology.
Methods
Protein expression and purification
A multicistronic expression vector encoding YscG and
YscE was assembled by Gateway multisite recombina-
tional cloning. Ribosome-binding sites and the appro-
priate attB recombination sites were added by PCR. YscG
and YscE were inserted into pDONR208 and pDONR209,
827 Structure of the YscEFG Complexrespectively (Invitrogen, Carlsbad, CA, USA). The genes
were sequence-verified and subsequently recombined into
pDEST-HisMBP
38 to create the multicistronic expression
vector pBA1578. The open reading frame encoding YscF
(residues 2–87) was amplified from Y. pestis genomic DNA
and inserted first into pDONR201 and then into the
destination vector pDEST-3 (Invitrogen) to generate
expression vector pYscF2. The recombinant proteins
were expressed in E. coli BL21(DE3) CodonPlus-RIL cells
(Stratagene, La Jolla, CA), which were induced at mid-log
phase with 1 mM IPTG for 4 h. Cells containing the
expression vector pBA1578 were resuspended in buffer A
(50 mM sodium phosphate, pH 8.0, 150 mM NaCl, and
25 mM imidazole) with ethylenediaminetetraacetic acid
(EDTA)-free protease inhibitor cocktail tablets (Roche
Molecular Biochemicals, Indianapolis, IN), lysed using
an APV-1000 homogenizer (Invensys, Roholmsvej, Den-
mark) at 69 MPa, and centrifuged at 30,000g for 30 min at
4 °C. The supernatant was loaded onto a 20 mL His-Trap
affinity column (GE Healthcare) and eluted with a linear
gradient from 25 to 250 mM imidazole in buffer A.
Fractions containing recombinant His6-MBP-YscG/YscE
were pooled, and the concentration of imidazole was
adjusted to 25 mM using an Amicon stirred cell. The free
YscE/YscG complex was recovered after digestion over-
night with 5 mg His6-tagged tobacco etch virus (TEV)
protease at 4 °C. Next, a 20 mL His-Trap affinity column
was employed to remove the His6-MBP fusion partner, the
His6-tagged TEV protease, and residual undigested fusion
protein. The concentrated flow-through fractions contain-
ing the YscE/YscG complex were subsequently loaded on
a 320 mL XK26/60 Sephacryl S-100 sizing column (GE
Healthcare) in buffer B (50 mM Tris, pH 7.2, and 150 mM
NaCl).
The cell pellet containing expression vector pYscF2 was
resuspended in buffer C (50 mM Tris, pH 7.2, and 200 mM
NaCl) with EDTA-free protease inhibitor cocktail tablets,
1 mM benzamidine HCl, and 5 mM DTT and lysed using
the same method as described above. The supernatant was
applied to a GSTPrep FF 16/10 column (GE Healthcare).
The column was washed with 10 column volumes of
buffer C; 5 column volumes of 50 mM Tris, pH 7.2, and
2 M NaCl buffer; and 10 column volumes of buffer B.
Next, a substantial molar excess of the YscE/YscG
complex was applied to the GST-YscF-charged GSTPrep
column, washed to baseline with buffer B, and treated
overnight with His6-tagged TEV protease. The YscEFG
complex was released from the column by the action of
TEV protease and recovered in the flow-through fraction.
This material was concentrated and applied to a HiPrep
26/60 Sephacryl S-100 HR column equilibrated in buffer D
[25 mM Tris, pH 7.2, 150 mM NaCl, 2 mM tris(2-
carboxyethyl)phosphine]. The peak fractions containing
the YscEFG complex were pooled and concentrated to
35 mg/mL. The final product was N95% pure by SDS-
PAGE electrophoresis, and the molecular weights of the
individual constituents of the YscEFG complex were
confirmed by electrospray mass spectroscopy. The sYs-
cEFG complex, which contains a truncated YscF protein
(residues 52–78), was expressed and purified by a similar
method. Selenomethionine was incorporated into the
YscEFG complex by the method of Doublie.
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CD spectroscopy
CD spectra were measured on an Aviv Model 202
spectrometer at 25 °C in a 1 mm cell in 25 mM Tris, pH 7.2,
150 mM NaCl, and 2 mMtris(2-carboxyethyl)phosphine at
protein concentrations of 0.35 mg/mL for both YscEFG
and sYscEFG samples. The thermodynamic stability was
recorded at 222 nm by monitoring the CD signal at 25–
90 °C with a scan rate of 1 °C/min for increasing
temperature assay. The spectra were corrected against
those of the buffer reference.
Limited proteolysis analysis of YscEFG complex
A 1 mg/mL stock solution of thermolysin (Roche
Molecular Biochemicals) in 1  thermolysin buffer
(10 mM Tris–HCl, pH 8.0, 2 mM CaCl2, 150 mM NaCl,
and 5% glycerol) was used for the limited proteolysis
experiments. The YscEFG stock solution contains the
protein at 2 mg/mL in buffer D. The five individual
reactions were composed of 25  L of YscEFG stock
solution, 25  L of 2  thermolysin buffer, and 0.5  L of
serial 1:4 dilutions of the thermolysin stock solution. The
reactions were allowed to proceed for 1 h at 37 °C until
termination by adding 2  L of 0.5 M EDTA. The reaction
products were initially analyzed by SDS-PAGE. The
precise molecular weights of the fragments were mea-
sured by electrospray mass spectrometry.
Crystallization and data collection
Crystals of the YscEFG complex were grown at 18 °C
using sitting drop vapor diffusion with protein to well
solution (0.2 M ammonium fluoride and 20% polyethylene
glycol 3350) at 1:3 (v/v). Crystals appeared within 3 days.
The crystals belong to the space group P21212. The solvent
content of the crystal was estimated to be approximately
33% (v/v) with a Matthews coefficient (VM) of 1.8 Å
3 Da
 1
for one heterotrimer in the asymmetric unit. The unit cell
has dimensions of a=74.50 Å, b=94.54 Å, and c=31.30 Å.
Crystals were equilibrated in a cryoprotectant composed
of reservoir buffer plus 10% (v/v) glycerol and were flash-
frozen in a cold nitrogen stream at  170 °C. One peak data
set was collected at the SER-CAT beamline 22-ID (Ad-
vanced Photon Source, Argonne National Laboratory).
Data were processed and scaled using the HKL2000 pro-
gram suite.40 Data collection and processing statistics are
summarized in Table 1.
Structure determination and refinement
The structure of Se-YscEFG was solved initially by the
Se-SAD method at 1.8 Å. Initial phases were obtained at
1.8 Å with a figure of merit of 0.261 using the program
CNS.
41 Eight of the 10 selenium atoms per asymmetric
unit were located. Phases were improved by density
modification using CNS,
41 and this led to a figure of merit
of 0.799. An experimental map was then generated for
model building. Nearly the entire backbone and most of
the side chains could be traced in the program O.
42 The
model was completed by alternating between manual
building and refinement with the program CNS. Residues
1–9 and 64–66 of YscE, residues 2–49 of YscF, and residues
1–2 and 115 of YscG were not visible in the electron
density. The final 1.8 Å refined structure of the YscEFG
complex consists of 204 amino acid residues and 227 water
molecules. Model quality was verified with PROCHECK.
43
All nonglycine residues reside either in the most favorable
regions or in the allowed regions of the Ramachandran
plot. Model refinement statistics are listed in Table 1.
All figures were generated with the graphics program
PyMOL.
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828 Structure of the YscEFG ComplexCoordinates
The atomic coordinates and structure factors for the
YscEFG complex were deposited in the Research Colla-
boratory for Structural Bioinformatics PDB with accession
code 2P58.
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